Physician profile
Majid A Basit
NPI 1609078112
$56,024.98
in general payments reported to CMS, 2019-2025
31 companies · $3,684 in 2025
The $3,684 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,132 · 2020: $8,595 · 2021: $4,887 · 2022: $16K · 2023: $8,342 · 2024: $8,782 · 2025: $3,684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,650 · Food and Beverage: $8,500 · Travel and Lodging: $3,563 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,650.00 |
| Food and Beverage | $8,500.41 |
| Travel and Lodging | $3,563.28 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $35,435.70 | 2019-2024 | Farxiga, Brilinta, Lokelma |
| Medtronic Vascular, INC. | $4,868.21 | 2019 | |
| Abbott Laboratories | $4,765.06 | 2019-2025 | Supera, Cardiomems, Aveir |
| Boston Scientific Corporation | $2,152.02 | 2019-2025 | Watchman Access System, Watchman Flx, Bodyguardian |
| Amgen INC. | $2,072.12 | 2020-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,013.65 | 2020-2025 | Jardiance |
| Shockwave Medical, INC | $981.42 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Sanofi-Aventis U.S. LLC | $918.64 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $642.21 | 2019-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $612.77 | 2022-2025 | |
| Actelion Pharmaceuticals US, INC. | $485.37 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Abiomed | $368.19 | 2019 | |
| Janssen Pharmaceuticals, INC | $342.64 | 2021-2024 | Xarelto |
| Impulse Dynamics (USA) INC. | $266.28 | 2023-2025 | Optimizer, Optimizer |
| Merck Sharp & Dohme LLC | $236.48 | 2022-2024 | Verquvo |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $156.75 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $122.83 | 2020-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $122.78 | 2022-2025 | Wegovy |
| Biosense Webster, INC. | $91.38 | 2025 | Carto 3 |
| Cardiovascular Systems INC. | $76.57 | 2019-2020 | |
| Scpharmaceuticals INC. | $52.20 | 2025 | |
| Axonics, INC. | $43.99 | 2023-2024 | Axonics |
| Baxter Healthcare | $33.48 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $27.89 | 2025 | |
| Phathom Pharmaceuticals, INC. | $24.07 | 2024 | Voquezna |
| Zoll Medical Corporation | $23.35 | 2023 | |
| Sanofi Pasteur INC. | $21.10 | 2024 | |
| Irhythm Technologies, INC. | $19.25 | 2024 | Zio Xt Patch, Zio Monitor |
| Zoll Circulation INC | $17.88 | 2023 | Temperature Management System, Temperature Management System Start-Up Kit, Catheter |
| Preventice Services, LLC | $15.55 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $15.15 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Majid Basit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.